[ Price : $8.95]
FDA warns San Diego, CA-based Samm Solutions about objectionable conditions in its role as the testing facility for two nonclinica...[ Price : $8.95]
FDA accepts for priority review an X4 Pharmaceuticals NDA for once-daily, oral mavorixafor to treat individuals aged 12 and older ...[ Price : $8.95]
FDA approves a Tenaya Therapeutics IND for the company to begin a Phase 1b trial of TN-401, an adeno-associated virus serotype 9-b...[ Price : $8.95]
AdvaMed tells the National Cyber Director about domestic and international efforts involving FDA to harmonize medical device cyber...[ Price : $8.95]
Asensus Surgical recalls its Senhance Surgical System due to the potential for the devices to malfunction.[ Price : $8.95]
Federal Register notice: FDA determines that 17 listed drug products were not withdrawn from sale for safety or efficacy reasons.[ Price : $8.95]
FDA approves an Amgen BLA for Wezlana (ustekinumab-auub), an interchangeable biosimilar to Janssens Stelara for multiple inflammat...[ Price : $8.95]
FDA warns Denver, CO-based WAVi Co. about multiple violations in its manufacturing and distribution of the WAVi Desktop, an unappr...